These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6155275)

  • 1. Biochemical assessment of the central 5-HT agonist activity of RU 24969 (a piperidinyl indole).
    Euvrard C; Boissier JR
    Eur J Pharmacol; 1980 Apr; 63(1):65-72. PubMed ID: 6155275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of acute hypercapnia on cerebral indole amine metabolism.
    MacMillan V
    Can J Physiol Pharmacol; 1978 Apr; 56(2):223-6. PubMed ID: 305815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probenecid-induced increase of 5-hydroxytryptamine synthesis in rat brain, as measured by formation of 5-hydroxytryptophan.
    van Wijk M; Sebens JB; Korf J
    Psychopharmacology (Berl); 1979 Feb; 60(3):229-35. PubMed ID: 108699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT1 receptor agonist RU-24969 decreases 5-hydroxytryptamine (5-HT) release and metabolism in the rat frontal cortex in vitro and in vivo.
    Brazell MP; Marsden CA; Nisbet AP; Routledge C
    Br J Pharmacol; 1985 Sep; 86(1):209-16. PubMed ID: 2413936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ipsapirone on the level of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in some regions of the rat brain.
    Gołembiowska K
    Pol J Pharmacol Pharm; 1989; 41(1):33-9. PubMed ID: 2479937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the anticonvulsant valproic acid on cerebral indole amine metabolism.
    MacMillan V
    Can J Physiol Pharmacol; 1979 Aug; 57(8):843-7. PubMed ID: 387187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo.
    O'Connell MT; Portas CM; Sarna GS; Curzon G
    Br J Pharmacol; 1991 Apr; 102(4):831-6. PubMed ID: 1713108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic mianserin administration on serotonin metabolism and receptors in the 5-hydroxytryptophan depression model.
    Akiyoshi J; Tsuchiyama K; Mizobe Y; Nakamura M; Kuranaga H; Nagayama H
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):165-79. PubMed ID: 7509496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist.
    Rënyi L; Evenden JL; Fowler CJ; Jerning E; Kelder D; Lake-Bakaar D; Larsson LG; Mohell N; Sällemark M; Ross SB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):883-93. PubMed ID: 11714872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between brain indole levels and severity of posthypoxic myoclonus in rats.
    Matsumoto RR; Aziz N; Truong DD
    Pharmacol Biochem Behav; 1995 Apr; 50(4):533-8. PubMed ID: 7542390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of imidazole-4-acetic acid on cerebral indole amine metabolism.
    MacMillan V
    Can J Physiol Pharmacol; 1982 Mar; 60(3):308-12. PubMed ID: 6176303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptophol and 5-hydroxyindoleacetic acid levels in rat brain: effects of various drugs affecting serotonergic transmitter mechanisms.
    Beck O; Lundman A; Jonsson G
    J Neural Transm; 1987; 69(3-4):287-98. PubMed ID: 2442302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra.
    Bouhelal R; Smounya L; Bockaert J
    Eur J Pharmacol; 1988 Jul; 151(2):189-96. PubMed ID: 2971554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 5-hydroxytryptophan in the isolated perfused rat lung.
    Ben-Harari RR; Parent Ermini A; Kleinerman J
    Pharmacology; 1990; 41(5):272-9. PubMed ID: 1709288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical and behavioural studies with RU-24969 in the rat.
    Carli M; Invernizzi R; Cervo L; Samanin R
    Psychopharmacology (Berl); 1988; 94(3):359-64. PubMed ID: 3128812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain.
    Löscher W; Pagliusi SR; Müller F
    Neuropharmacology; 1984 Sep; 23(9):1041-8. PubMed ID: 6083501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.